Comment on “Efficacy and safety of oral phosphodiesterase 5 inhibitor for erectile dysfunction: a network meta-analysis and multicriteria decision”

被引：0
|
作者：
Kumar Rajiv Ranjan
Gopal Sharma
机构：
[1] PGIMER,Department of Urology
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Phosphodiesterase 5 inhibitor; Erectile dysfunction; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2815 / 2816
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in type 1 diabetic patients with erectile dysfunction
    Ziegler, D
    Merfort, F
    Van Ahlen, H
    Reblin, T
    Neureither, M
    [J]. DIABETES, 2005, 54 : A127 - A127
  • [22] COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND PERCUTANEOUS CORONARY INTERVENTION: A NETWORK META-ANALYSIS WITH MULTICRITERIA DECISION ANALYSIS
    Mainka, F. F.
    Riveros, B. S.
    Ferreira, V. L.
    Mendes, A. M.
    Marques, G. L.
    Tonin, F. S.
    Pontarolo, R.
    [J]. VALUE IN HEALTH, 2020, 23 : S104 - S104
  • [23] Reply to ‘Efficacy and safety of phosphodiesterase-5 inhibitors for treatment of erectile dysfunction secondary to spinal cord injury: a systemic review and meta-analysis’
    Jurgen Pannek
    [J]. Spinal Cord Series and Cases, 3 (1)
  • [24] Placebo Responses Among Men With Erectile Dysfunction Enrolled in Phosphodiesterase 5 Inhibitor Trials A Systematic Review and Meta-analysis
    Stridh, Alexander
    Ponten, Moa
    Arver, Stefan
    Kirsch, Irving
    Abe, Christoph
    Jensen, Karin B.
    [J]. JAMA NETWORK OPEN, 2020, 3 (03) : E201423
  • [25] ASSESSMENT OF COMBINATION THERAPIES VERSUS PHOSPHODIESTERASE TYPE 5 INHIBITOR MONOTHERAPY FOR ERECTILE DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Mykoniatis, I
    Pyrgidis, N.
    Sokolakis, I
    Ouranidis, A.
    Sountoulides, P.
    Haidich, A.
    Van Renterghem, K.
    Hatzichristodoulou, G.
    Hatzichristou, D.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2022, 19 (05): : S125 - S125
  • [26] Efficacy and tolerability of tadalafil, a novel phosphodiesterase 5 inhibitor, in treatment of erectile dysfunction
    Padma-Nathan, H
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (9A): : 19M - 25M
  • [27] Efficacy and Safety of Udenafil for Erectile Dysfunction: A Meta-analysis of Randomized Controlled Trials
    Ding, Hui
    Du, Wan
    Wang, Hanzhang
    Zhang, Liyuan
    Wang, ZhiPing
    Du, Chengwei
    Tao, Yan
    [J]. UROLOGY, 2012, 80 (01) : 134 - 139
  • [28] Safety and efficacy of avanafil, a new phosphodiesterase type-5 (PDE-5) inhibitor for treating erectile dysfunction
    Kaufman, JM
    Dietrich, JW
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 299 - 299
  • [29] Influence of age on the efficacy and safety of vardenafil, a novel phosphodiesterase-5 inhibitor, for the treatment of erectile dysfunction.
    Donatucci, C
    Karlin, G
    Goldfischer, E
    Cohen, S
    Thibonnier, M
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (04) : S107 - S107
  • [30] Efficacy of Phosphodiesterase-5 Inhibitor in Men With Premature Ejaculation: A New Systematic Review and Meta-analysis COMMENT
    Kovac, Jason R.
    [J]. UROLOGY, 2015, 86 (05) : 954 - 955
12345